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Abstract
Background: Hospital-treated deliberate self-harm (DSH) is common, costly and has high repetition rates. Since
brief contact interventions (BCIs) may reduce the risk of DSH repetition, we aim to evaluate whether a SMS (Short
Message Service) text message Intervention plus Treatment As Usual (TAU) compared to TAU alone will reduce
hospital DSH re-presentation rates in Western Sydney public hospitals in Australia.
Methods/design: Our study is a 24-month randomized controlled trial (RCT). Adult patients who present with DSH
to hospital emergency, psychiatric, and mental health triage and assessment departments will be randomly assigned to
an Intervention condition plus TAU receiving nine SMS text messages at 1, 2, 3, 4, 5, 6, 8, 10 and 12-months
post-discharge. Each message will contain telephone numbers for two mental health crises support tele-services.
Primary outcomes will be the difference in the number of DSH re-presentations, and the time to first re-presentation,
within 12-months of discharge.
Discussion: This study protocol describes the design and implementation of an RCT using SMS text messages, which
aim to reduce hospital re-presentation rates for DSH. Positive study findings would support the translation of
an SMS-aftercare protocol into mental health services at minimal expense.
Trial registration and ethics approval: This trial has been registered with the Australian and New Zealand
Clinical Trials Registry (Trial registration: ACTRN12617000607370. Registered 28 April 2017) and has been
approved by two Local Health Districts (LHDs). Western Sydney LHD Human Research Ethics Committee
approved the study for Westmead Hospital and Blacktown Hospital (Protocol: HREC/16/WMEAD/336). Nepean
Blue Mountains LHD Research Governance Office approved the study for Nepean Hospital (SSA/16/Nepean/
170).
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Background
Hospital-treated DSH is common [1] and costly [2].
Repetition of DSH within 1 year of hospital admission
occurs at a median proportion of 15% (interquartile
range 12–25%) [1].
DSH is associated with a range of psychiatric issues
[3], an increased risk of suicide attempts, and suicide [3,
4]. In Australia, DSH accounted for 6% of all hospita-
lised injury cases during 2012–2013 and four-billion
dollars in healthcare expenditure annually, making pre-
vention and early intervention an Australian national
health priority [5]. Hospital-treated DSH predominantly
includes deliberate self-poisoning (DSP) (approximately
90% of DSH cases) and other various methods, includ-
ing, cutting, hanging, jumping, and burning [1].
Hospital-treated DSH is associated with an increased
risk of suicide death, highlighting the importance of ef-
fective prevention and early intervention strategies.
BCIs, such as follow-up postcards, supportive letters, or
phone calls have previously been shown to be associated
with reductions in hospital re-presentation event rates. A
recent systematic review and meta-analysis of BCIs for re-
ducing DSH (letters, telephone calls and crisis “green
cards”) found a non-significant benefit for any episode of
repeat DSH (binary outcome) and a significant benefit for
repetition event rates [6]. The individual studies identified
in the systematic review and meta-analysis generally
lacked statistical power and varied considerably in inter-
vention timeframes and methodologies, highlighting the
need for well-designed, large, RCTs to determine the effi-
cacy of these BCIs.
SMS text messaging provides more immediate com-
munication and may be a more effective intervention
than postcards [6, 7]. Text messaging has been associ-
ated with positive outcomes for hospital patients in a
pilot study [8] and in a prospective study [9]. These
studies demonstrated the technical feasibility and accept-
ability of text messaging outreach in post-acute suicide
attempters in different cultural contexts. Most partici-
pants considered the text message contacts an accept-
able and useful form of help and indicated they wished
to continue receiving those text messages.
If an SMS text messaging follow-up intervention is
found to be effective in reducing DSH re-presentations,
it would provide a lower-cost, higher coverage medical




The aim of this study is to investigate whether Treat-
ment As Usual (TAU) aftercare for DSH patients plus
supportive SMS text messages delivered over 1 year re-
duce DSH re-presentations to hospital, compared to
TAU alone. Our hypotheses are: 1) SMS text messages
plus TAU will be associated with a significantly lower
incidence event rate of hospital DSH re-presentations,
compared to the patient group receiving TAU; and 2)
SMS text messages plus TAU will be associated with a
significantly greater time to first hospital DSH re-pres-
entation compared to TAU.
Study design
A RCT will be conducted in three selected public hospi-
tals in Western Sydney, Australia, and will have a
24-month recruitment period and a 12-month follow-up
period. The study protocol is like the methodology
employed in an earlier study [10], which was a two-year
French multicenter RCT, comprising of DSH patients,
similar text messages, and an SMS outreach schedule of
48 h, 7 days, 15 days and, then monthly for 12-months.
Our study consists of a parallel design that will compare
a control group (TAU condition) with patients who re-
ceive an Intervention condition (i.e. SMS text messages
plus TAU). Outcome data on DSH will be obtained from
routinely collected hospital records, extracted by trained
research staff.
Setting
Our study will be conducted at three large, public hospi-
tals in Western Sydney; Nepean, Blacktown and West-
mead Hospitals.
Participants/Subjects
For the purpose of this study, participants will be defined
as patients who have randomly been allocated to the Inter-
vention condition and provide their informed consent to
receive text messages. Subjects will be defined as patients
who are randomly allocated to the TAU condition and do
not receive text messages. To be eligible for study inclu-
sion, patients must be: assessed at an emergency depart-
ment (ED) after presenting with DSH; at least 16-years
old; competent in reading and understanding English; and
have a mobile phone. Patients will be excluded from the
study if they: refuse to participate; do not have a mobile
phone; do not have a fixed Australian address or are
otherwise unable to provide informed consent.
Randomization, allocation, and materials
Participants/subjects will be stratified (first ever
hospital-treated DSH verses any subsequent episode),
then randomly assigned and enrolled into the study fol-
lowing the Zelen single-consent design [11]. Since
there are different repetition rates of DSH for initial
and subsequent DSH, participant/subject numbers will
initially be stratified by first or subsequent DSH pres-
entation. They will then be randomized within strata,
using random permuted blocks of size 6, to either the
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Intervention or control condition (TAU) using a
computer-generated randomization program.
Study materials, including an ‘Allocation Information
Sheet,’ will be organized within numbered envelopes,
with each hospital having at least two ‘enrolment boxes’
(document drawers) containing a full set of materials.
Research staff will confirm that the placement of re-
search materials and the Allocation Information Sheets
within envelopes match the randomized numbers gener-
ated from the randomization program (to prevent any
tampering with the allocation sequence).
Data collection
Clinical and demographic information of patients will be
recorded, including: presenting group (i.e. first DSH or
subsequent DSH presentation) randomized condition
(i.e. TAU or Intervention); mobile phone number; hos-
pital of study enrollment; key dates (admission, enroll-
ment, discharge, and deceased dates); clinical diagnoses;
primary DSH method; gender, birth date, place of resi-
dence, marital status, primary language spoken, Austra-
lian Aboriginality status, and ethnicity), Medical Record
Number, first name, and last name.
Procedure
The usual treating health and mental health clinicians
(Psychiatrists, Clinical Nurse Consultants, Registered
Nurses and Psychiatry Registrars) will assess patients at
EDs, Toxicology Centers, Psychiatric Emergency Care
Centers, and Mental Health Triage and Assessment
Centers. Clinicians will enroll eligible patients into the
Intervention or TAU conditions and record the name,
Medical Record Number, mobile phone number and
date of birth of participants/subjects on Allocation In-
formation Sheets. Envelopes will be supplied at study
commencement, including at least 500 green envelopes
(numbered for first DSH presentation) and at least 500
blue envelopes (numbered for subsequent DSH presen-
tation). Allocation Information Sheets will be concealed
inside sealed envelopes and the allocating clinician will
draw the next numbered envelope for each participant/
subject form the appropriate stratification. Demographic
information will be collected by hospital administration
staff when patients first present to the ED.
Figure 1 outlines the methodological process that will
be followed for the SMS SOS Study. Allocation will
occur via numbered sealed envelopes. Upon enrolling
patients into the study, health professionals will attach a
patient identification label (which includes the patient’s
name, gender, date of birth and Medical Record Num-
ber) to an Allocation Information Sheet, which would be
drawn from a selected envelope. For patients allocated
to the Intervention condition, clinicians will explain that
they may receive text messages for up to 12-months post
discharge. Clinicians will provide patients in the
Eligibility Criteria applied to all 
participants/subjects presenting 
with DSH during recruitment 
Eligible patients Ineligible patients
Usual hospital follow-up 
treatment (TAU)                       
n=398
12 month                
follow-up
12 month               
follow-up
TAU plus SMS follow-up (TAU + SMS)
n=398
SMS message at 1,2,3,4,5,6,8,10, and 12 
months post index DSH on discharge
Randomize
Stratify by ‘first’ or 
‘subsequent’ presentation for 
DSH
Fig. 1 RCT design flowchart
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Intervention condition with a Participant Information
Sheet and they will obtain written consent. To reduce
unnecessary patient burden, patients allocated to the
control condition (TAU) will not be recruited by clini-
cians, as per the Zelen single-consent design [11].
To reduce the chance of patients being re-enrolled
into the study, treating clinicians will review an
Enrolled Patients List and a Patient Exclusion List
placed in a folder above each enrollment box to be
checked before recruitment. A hardcopy of the En-
rolled Patients List and the Patient Exclusion List will
be used due to the limited capacity of the patient
electronic medical record system to reliably identify
(‘flag’) to clinicians those patients who have previously
been enrolled into the study. The folder will also con-
tain an Enrollment Procedure Flowchart (Fig. 2) re-
garding the enrollment process and the definition of
DSH used for the study.
Fig. 2 Enrolment procedure flowchart
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Intervention
Patients in the Intervention condition will receive TAU
plus a series of supportive SMS text messages. The Inter-
vention condition will consist of nine text messages in
total, which were developed based on feedback received
from a panel of lived experience mental health consultants.
Seven people with mental health problems and/or a history
of DSH informed the development of the text messages.
According to the feedback received, each text message was
clear and easy to read, and suited the purpose of making
brief contact and offering support phone numbers.
The text messages will be personalized with the names
of patients and will be sent with identical outreach
schedules. Nine automated text messages will be sent to
patients assigned to the Intervention condition at
months 1, 2, 3, 4, 5, 6, 8, 10, and 12 post-discharge. This
is like the contact schedule employed in the Postcards
from the Edge study [12]. There will be three different
SMS text messages sent to participants, which express
concern for their wellbeing and encourage them to tele-
phone clinical crises and mental health support services,
including Lifeline and NSW Health’s ‘Mental Health
Line,’ if needed. Patients in the Intervention condition
will be advised once in the first text message that they
will not be able to directly reply to text messages. The
three text messages sent to patients in the Intervention
condition are as follows:
Text message 1.
Dear [name].
We hope that things have been going well for you since
we last had contact.
Just a reminder that the 24-h contact line (13 11 14)
is there if you’d like to connect with someone and
Helpline staff (1800 011511) can put you in touch
with your local health service if needed.




We hope that you’ve been ok since our last contact.
We’re just checking in with you.
A 24-h phone line is there for you in case you’d like to
connect with someone (13 11 14) or to contact your




Just checking in with you.
A reminder that help is there if you need it. Just call
(13 11 14) or (1800 011511) for support.
Best wishes.
The SMS text messages will be scheduled for auto-
matic distribution via a private and as secure as possible
medium, considering available Australian telecommu-
nications providers. The telecommunications provider
was selected based on its capacity to provide both an
automated service with message variants and to
personalize messages with the names of specific recip-
ients. These features will support large scale, low cost
delivery of a future mental health aftercare service for
this population. The three SMS text messages will be
delivered to participants according to the schedule
detailed in Table 1.
Treatment as usual (control) condition
Patients assigned to the control condition will receive
TAU without SMS text messages. This will vary for each
patient but usually consists of hospital and/or commu-
nity mental health contact with the presenting individ-
ual, typically within 24-h of their hospital presentation,
and a follow-up program of care including clinical re-
assessment, appropriate mental health services, drug and
alcohol services and/or general practitioner follow-up
and indicated psychological therapies.
Outcome measures
As primary endpoints, we will assess at 6 and 12-months
post-index discharge, i) the number of hospital DSH
re-presentations in each condition (repetition event rate)
and ii) the time to first re-presentation in each condi-
tion. Secondary end-points include i) any DSH
re-presentation, ii) suicide mortality, and iii) all-cause
mortality. Mortality data will be obtained from routinely
collected data sources available through NSW Health,
other government agencies, and the Centre for Health
Record Linkage (CheReL).
Table 1 Delivery schedule for the three supportive SMS text
messages
Text message Month/s to be delivered
1 1 only
2 2, 4, 6 and 10
3 3, 5, 8 and 12
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Sample size calculation
Assuming an incidence rate ratio (based on event rates) of
RR = 0.66 [13] for the Intervention condition compared to
TAU, with a 5% significance level, 80% power, and 10% ad-
justment for correlation of individuals within hospitals, a
total sample size of 796 participants/subjects is required
(398 participants in the Intervention condition and 398
subjects in the control condition). We have also assumed
a median survival time (time to first repetition) in the
TAU condition of 4.3 years. Currently ~ 15% in the usual
care group who present for DSH re-present within the fol-
lowing 12-months, or a probability of survival of 0.85. Me-
dian survival (m) after 1-year (t) in the usual care group is
t*loge(1/2)loge(p = 4.3 years). For assessing differences in
median time to first repetition, assuming a median sur-
vival time in the usual care group of 73.5 days [12] and a
similar relative difference in event rates between Interven-
tion and TAU conditions as above (RR = 0.66), [13] the es-
timated median survival time in the Intervention
condition is 121.8 days, which requires a total sample size
of 138 participants/subjects (69 participants in the Inter-
vention condition and 69 subjects in the TAU condition),
with 5% significance and 80% power, and 10% adjustment
for correlation of individuals within hospitals. The number
of patients likely to die within the study period is very
small. A previous longitudinal study in a similar Austra-
lian hospital setting [12] found a 1% suicide rate after 24
months and nearly a 2% suicide rate after 5 years.
Statistical methods
Participant/subject characteristics will be summarized
using mean, standard deviation, median and inter-quar-
tile range. Categorical variables will be summarized
using frequencies, percentages and 95% confidence in-
tervals. Means will be compared between the Interven-
tion condition and TAU condition using the t-test or
Mann-Whitney test. Comparisons of proportions be-
tween conditions will be performed using the Chi square
test or Fisher’s exact test, as appropriate. Differences in
the incidence of subsequent DSH between the Interven-
tion and TAU conditions at 6 and 12months will be in-
vestigated using multi-level negative binomial regression
models (individuals nested within hospitals) to estimate
the incidence risk ratios (IRR) and absolute risk differ-
ences based on incidence proportions in an intention to
treat analysis. Adjustment for potential confounders
identified from descriptive analyses will also be included
in multivariate regression models as appropriate.
Relative differences in time to first subsequent DSH
event between Intervention and control conditions at 6
and 12 months will also be investigated using multi-level
Cox proportional hazard regression models (individuals
nested within hospitals) to estimate hazard ratios (HR),
with adjustment for potential confounders as
appropriate. Kaplan-Meier survivorship functions and
clustered log-rank tests will also be calculated to assess
differences between Intervention and TAU conditions,
with median time to first DSH event compared for Inter-
vention and TAU conditions.
Ethical considerations
Participants in the Intervention condition will be in-
formed that they can withdraw from the study at any
time by contacting the relevant study coordinator at the
hospital of original enrolment. The study has been ap-
proved by the NSW Ministry of Health and the Western
Sydney Local Health District Human Research Ethics
Committee (Protocol Number: HREC/16/WMEAD/
336). Site specific approval was granted by the Nepean
Blue Mountains Local Health District Research Govern-
ance Office (SSA/16/Nepean/170).
Discussion
The present article details the research protocol for an
RCT to investigate the impacts of SMS aftercare on DSH
hospital re-presentations. BCIs have been found to be ef-
fective at reducing DSH re-presentation rates. SMS after-
care offers a more immediate contact medium, which is
increasingly relevant across all demographic groups, but
especially among young people; a key risk group for DSH
and suicide. SMS aftercare also has the potential to aug-
ment existing mental health programs and provides a
ready platform for the provision of psychosocial informa-
tion and interactive tools. Should SMS aftercare prove ef-
fective in reducing DSH re-presentations, it would allow
for a significantly more flexible, low-cost and deliverable
medical follow-up system than what currently exists.
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